Mahamaya Lifesciences Limited has officially informed BSE Limited about its exemption from corporate governance compliance requirements under SEBI regulations. The company submitted a formal communication dated April 15, 2026, to BSE's Listing Compliance Department regarding this regulatory exemption.

Regulatory Exemption Details

The company has invoked the non-applicability criteria provided under Regulation 15(2)(b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This exemption is specifically available to companies whose equity shares are listed on the BSE SME Platform.

Impact on Compliance Requirements

Due to this exemption, Mahamaya Lifesciences Limited is not required to file corporate governance reports as mandated under Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The exemption covers:

• Quarterly corporate governance reports
• Half-yearly corporate governance reports
• Yearly corporate governance reports

Company Information

Mahamaya Lifesciences Limited, formerly known as Mahamaya Lifesciences Pvt. Ltd., operates from its registered office located at Spaze ITech Park, Sector-49, Sohna Road, Gurugram, Haryana. The company holds CIN L24233DL2002PLC115261 and maintains ISO 9001:2015 certification.

Official Communication

The formal notification was signed by Shilpi Bhardwaj, Company Secretary & Compliance Officer (Membership No.: A24444), and submitted to BSE Limited for official records. The communication ensures transparency regarding the company's compliance status under current SEBI regulations for SME-listed entities.

Mahamaya Lifesciences Limited has filed its quarterly compliance certificate with the Bombay Stock Exchange for the quarter ended March 31, 2026, fulfilling its obligations under SEBI (Depositories and Participants) Regulations, 2018. The submission demonstrates the company's commitment to maintaining regulatory compliance and transparency with market authorities.

Regulatory Compliance Details

The certificate was submitted pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, dated April 4, 2026. Company Secretary and Compliance Officer Shilpi Bhardwaj signed the submission on behalf of Mahamaya Lifesciences Limited, ensuring proper authorization and accountability for the regulatory filing.

Share Dematerialization Status

KFin Technologies Limited, serving as the company's Registrar and Share Transfer Agent, confirmed that Regulation 74(5) is not applicable to Mahamaya Lifesciences Limited. This determination stems from the fact that the entire shareholding of the company remains in dematerialized form, with no physical share certificates outstanding.

The registrar's certificate, dated April 2, 2026, and signed by Senior Manager S Balaji Reddy, specifically states that no requests for rematerialization were received from any company members during the quarter ended March 31, 2026. This indicates complete digital holding of shares among all shareholders.

Corporate Information

Mahamaya Lifesciences Limited, formerly known as Mahamaya Lifesciences Pvt. Ltd., operates from its registered office located at Tower B-3, Spaze ITech Park, Sector-49, Sohna Road, Gurugram. The company holds ISO 9001:2015 certification and maintains its corporate identification number as U24233DL2002PLC115261.

Registrar Operations

KFin Technologies Limited operates from multiple locations to serve its clients effectively. The operations center is situated at Selenium Tower B, Financial District, Nanakramguda, Hyderabad, while the registered office is located at The Centrium, Thane West. This infrastructure enables comprehensive registrar and share transfer services for listed companies.

The quarterly compliance certificate filing reflects standard corporate governance practices and regulatory adherence requirements for publicly listed companies in India. Such submissions ensure transparency and maintain investor confidence in the company's operational compliance framework.